A rise of the serum level of von Willebrand factor occurs before clinical manifestation of the severe form of ovarian hyperstimulation syndrome

Journal of Assisted Reproduction and Genetics

Volumn 18, Issue 2, 2001, Pages 114-119

  Ogawa, Shuichi ^a   Minakami, Hisanori ^a   Araki, Shigeo ^a   Ohno, Takashi ^a   Motoyama, Mitsuhiro ^b   Shibahara, Hiroaki ^a   Sato, Ikuo ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Utsunomiya Central Clinic   (Japan)

Author keywords

Capillary permeability; IVF ET; Ovarian hyperstimulation syndrome; Prediction; Von Willebrand factor

Indexed keywords

VASCULOTROPIN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD LEVEL; CAPILLARY PERMEABILITY; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE SEVERITY; EMBRYO TRANSFER; ENDOTHELIUM CELL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OOCYTE; OVARY DISEASE; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; BLOOD PROTEINS; EMBRYO TRANSFER; ENDOTHELIAL GROWTH FACTORS; FEMALE; FERTILIZATION IN VITRO; GAMETE INTRAFALLOPIAN TRANSFER; HEMATOCRIT; HUMANS; LEUKOCYTE COUNT; LYMPHOKINES; MALE; OOCYTES; OVARIAN HYPERSTIMULATION SYNDROME; PREDICTIVE VALUE OF TESTS; PREGNANCY; RETROSPECTIVE STUDIES; SERUM ALBUMIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VON WILLEBRAND FACTOR;

FALLOPIA;

EID: 0035083595     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026590910462     Document Type: Article

References (29)

1. Ovarian hyperstimulation syndrome: A current survey
2. Ovarian hyperstimulation syndrome
3. Risk factors and prognostic variables in the ovarian hyper-stimulation syndrome
4. The management of predicted ovarian hyperstimulation involving gonadotropin-releasing hormone analog with elective cryopreservation of all pre-embryos
5. Transcapillary fluid dynamics during ovarian stimulation for in vitro fertilization
6. Gonadotrophin releasing hormone agonist and ovarian hyperstimulation syndrome in assisted reproduction
7. Prevention and treatment of ovarian hyperstimulation syndrome
8. Increased capillary permeability induced by human follicular fluid: A hypothesis for an ovarian origin of the hyperstimulation syndrome
9. Ovarian hyperstimulation syndrome (OHSS): How much do we really know about it?
10. The potential relevance of cytokines to ovarian physiology: The emerging role of resident ovarian cells of the white blood cell series
11. The pathogenesis of the ovarian hyperstimulation syndrome (OHSS): A possible role for ovarian renin
12. Elevated level of interleukin-6 in ascites and serum from women with ovarian hyperstimulation syndrome
13. High levels of immunoreactive endothelin-1 in human follicular fluids
14. Angiotensin II immunoreactivity is elevated in ascites during severe ovarian hyperstimulation syndrome: Implications for pathophysiology and clinical management
15. Role of intravenous albumin in the prevention of severe ovarian hyperstimulation syndrome
16. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome
17. The role of von Willebrand factor in pre-eclampsia
18. Pre-eclampsia is associated with a serum factor cytotoxic to human endothelial cells
19. Von Willebrand factor: An endothelial maker to monitor in vitro fertilization patients with ovarian hyperstimulation syndrome
20. Evaluation of a new automated ELISA test for von Willebrand factor using two monoclonal antibodies
21. Molecular and cellular biology of von Willebrand factor
22. The von Willebrand factor gene and genetics of von Willebrand's disease
23. Unusually large plasma factor VIII: Von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenia purpura
24. Von Willebr and factor: Clinical features of inherited and acquired disorders
25. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome
26. Ovarian derived prorenin angiotensin cascade in human reproduction
27. Characterization of intraperitoneal cytokines and nitrites in women with severe OHSS - A multicenter study
28. Vascular endothelial growth factor (VEGF) messenger ribonucleic acid expression in luteinized human granulosa cells in vitro
29. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid